Salarius Pharmaceuticals News - SLRX

Company Name	Stock Ticker Symbol	Market	Type
Salarius Pharmaceuticals Inc	SLRX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.011	-2.20%	0.49	12:32:25

Open Price	Low Price	High Price	Close Price	Prev Close
0.5096	0.49	0.5198		0.501

more quote information »

Recent News

Date	Time	Source	Heading
3/22/2024	16:05	GLOBE	Salarius Pharmaceuticals Reports Fourth Quarter and Full..
3/06/2024	16:02	EDGAR2	Form 8-K - Current report
2/22/2024	16:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	16:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	08:00	GLOBE	Salarius Provides Update on Strategic Review Process and..
1/16/2024	08:00	GLOBE	Salarius Pharmaceuticals Issued U.S. Patent for..
1/03/2024	08:30	GLOBE	Investigator-initiated Phase 1/2 Clinical Trial Using..
11/09/2023	17:04	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	08:30	GLOBE	Salarius Completes FDA Type B Meeting for Seclidemstat Ewing..
10/27/2023	15:57	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
9/06/2023	17:09	EDGAR2	Form 8-K - Current report
8/10/2023	16:14	EDGAR2	Form 8-K - Current report
8/10/2023	16:13	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:05	GLOBE	Salarius Pharmaceuticals Reports Second Quarter 2023..
8/08/2023	16:05	GLOBE	Salarius Pharmaceuticals Announces Plans to Explore..
7/12/2023	09:22	EDGAR2	Form 8-K - Current report
7/11/2023	08:30	GLOBE	Salarius Pharmaceuticals Receives FDA Clearance of SP-3164..
6/12/2023	08:00	GLOBE	Salarius Pharmaceuticals Presents SP-3164 Targeted Protein..
5/16/2023	16:05	GLOBE	Salarius Pharmaceuticals Announces Closing of $6 Million..
5/12/2023	08:00	GLOBE	Salarius Pharmaceuticals Announces $6 Million Private..
5/11/2023	08:00	GLOBE	Salarius Pharmaceuticals Reports First Quarter 2023..
5/09/2023	08:00	GLOBE	FDA Removes Partial Clinical Hold on Salarius..
5/01/2023	08:30	GLOBE	Salarius Pharmaceuticals Reports No Adverse Safety Signals..